Literature DB >> 8016595

Cancer morbidity among Danish female pharmacy technicians.

J Hansen1, J H Olsen.   

Abstract

OBJECTIVES: Pharmacy technicians maintain a substantial production and packing of pharmaceuticals and other chemicals, many of which are carcinogens. This study reports on cancer incidence among Danish female pharmacy assistants and dispensers.
METHODS: Altogether, 8499 compulsory members were identified in the archives of the Association of Danish Pharmacy Technicians and followed through the files of the Danish Cancer Registry (1970-1990); observed figures were compared with those expected on the basis of national cancer incidence rates.
RESULTS: The overall standardized incidence ratio [SIR] for cancer was 1.0 [N = 219, 95% confidence interval (95% CI) 0.8-1.1]. A 1.5-fold (N = 34; 95% CI 1.1-2.1) elevated risk of nonmelanoma skin cancer was found, especially for long-term pharmacy assistants (N = 15, SIR 2.8, 95% CI 1.6-4.6). An increased risk for non-Hodgkin's lymphoma appeared among long-term pharmacy dispensers (N = 5, SIR 3.7, 95% CI 1.2-8.9). In the entire group, the risk of tobacco-related tumors was significantly reduced (N = 8, SIRW 0.4, 95% CI 0.2-0.9), together with the probably socioeconomic-associated cervical cancer risk (N = 18, SIR 0.6, 95% CI 0.4-0.9).
CONCLUSIONS: Sunlight is usually the dominant cause of nonmelanoma and melanoma skin cancer, but occupational factors may have contributed in this study in view of the uncommon localization observed for many of these cancers and the unelevated melanoma risk. In addition to the increased risk of non-Hodgkin's lymphomas, which may have been associated with exposure to organic solvents, the results do not indicate any other notable cancer risks during the follow-up.

Entities:  

Mesh:

Year:  1994        PMID: 8016595     DOI: 10.5271/sjweh.1433

Source DB:  PubMed          Journal:  Scand J Work Environ Health        ISSN: 0355-3140            Impact factor:   5.024


  8 in total

Review 1.  Reproductive health risks associated with occupational exposures to antineoplastic drugs in health care settings: a review of the evidence.

Authors:  Thomas H Connor; Christina C Lawson; Martha Polovich; Melissa A McDiarmid
Journal:  J Occup Environ Med       Date:  2014-09       Impact factor: 2.162

2.  Occupation/industry and risk of non-Hodgkin's lymphoma in the United States.

Authors:  M Schenk; M P Purdue; J S Colt; P Hartge; A Blair; P Stewart; J R Cerhan; A J De Roos; W Cozen; R K Severson
Journal:  Occup Environ Med       Date:  2008-09-19       Impact factor: 4.402

3.  Reduction in surface contamination with antineoplastic drugs in 22 hospital pharmacies in the US following implementation of a closed-system drug transfer device.

Authors:  Paul J M Sessink; Thomas H Connor; James A Jorgenson; Timothy G Tyler
Journal:  J Oncol Pharm Pract       Date:  2010-02-15       Impact factor: 1.809

Review 4.  Occupational risk factors for female breast cancer: a review.

Authors:  M S Goldberg; F Labrèche
Journal:  Occup Environ Med       Date:  1996-03       Impact factor: 4.402

5.  Occupational exposure to cytotoxic drugs in two UK oncology wards.

Authors:  E Ziegler; Howard J Mason; P J Baxter
Journal:  Occup Environ Med       Date:  2002-09       Impact factor: 4.402

6.  Reduction in Surface Contamination With Cyclophosphamide in 30 US Hospital Pharmacies Following Implementation of a Closed-System Drug Transfer Device.

Authors:  Paul J M Sessink; Jason Trahan; Joseph W Coyne
Journal:  Hosp Pharm       Date:  2013-03

7.  Malignant tumors of the female reproductive system.

Authors:  Elisabete Weiderpass; France Labrèche
Journal:  Saf Health Work       Date:  2012-08-30

8.  Development and evaluation of adsorption sheet (HD safe sheet-U) using active carbon for the purpose of the preventing the contamination diffusion of urinary excreted anticancer drug.

Authors:  Junya Sato; Haruka Ohkubo; Yuki Sasaki; Makoto Yokoi; Yasunori Hotta; Kenzo Kudo
Journal:  J Pharm Health Care Sci       Date:  2017-06-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.